We report a patient with congenital chylothorax who also had neonatal thyrotoxicosis secondary to maternal Graves' disease. Fetal tachycardia with hydrops was detected at 28 weeks' gestational age. The fetus responded to antithyroid medication in utero but had persistent bilateral pleural effusion. At birth, he had respiratory distress due to massive pleural effusion. Cytologic studies of pleural fluid were consistent with chylothorax. To the best of our knowledge, the association of congenital chylothorax with fetal (neonatal) thyrotoxicosis, has not been reported previously.
Chylothorax is the most common cause of neonatal pleural effusion, and it is a rare cause of respiratory distress in the newborn with a mortality rate of 20%. 1, 2 Males are affected twice as frequently as females, and 60% of cases involve the right side of the chest. 3 Most cases of spontaneous congenital chylothorax have an unknown etiology. Congenital chylothorax has been reported in association with polyhydramnios, superior caval vein obstruction, Down's syndrome, Turner's syndrome, and Noonan's syndrome. 4 -7 We report a patient with neonatal thyrotoxicosis who presented at birth with severe respiratory distress due to massive bilateral chylothorax.
CASE REPORT
CH, a 1675-gm white male infant was born at 29 weeks' gestation by normal spontaneous vaginal delivery to a 19-year-old primigravida mother. Two months before conception, his mother was found to have Graves' disease. She received iodine-131 ablation therapy, and replacement therapy with levothyroxine sodium (Synthroid; Knoll Pharmaceuticals, Whippany, NJ) was started. During a regular prenatal follow-up at 28 weeks' gestation, fetal tachycardia with a rate of more than 180 beats/min was recorded. Fetal ultrasound revealed hydrops, with bilateral pleural effusions, pericardial effusion, and hydrocele. Thyroid function tests on the mother revealed thyrotoxicosis (Table 1) . Synthroid was discontinued and she was placed on propylthiouracil and propranolol. Four days later she was admitted to our institution and a follow-up fetal sonogram examination showed resolution of the fetal hydrops, with persistence of the bilateral pleural effusions (Figure 1 ). The heart function and anatomy on examination by fetal echocardiogram were normal; the heart rate was 134 beats/min. The mother's membranes ruptured at 29 weeks' gestation. She received four doses of steroids 48 hours before delivery; the Apgar scores were 0, 4, and 7 at 1, 5, and 7 minutes, respectively. The infant was immediately intubated and placed on a ventilator. A chest film revealed persistence of the massive bilateral pleural effusions ( Figure  2 ). Bilateral thoracocentesis was performed and approximately 300 ml of serous fluid were drained. There were 17,300 cells/mm of fluid, of which 73% were lymphocytes compared with 29% lymphocytes in the blood (Table 2 ). This high pleural fluid lymphocytosis is consistent with a diagnosis of chylothorax. 8, 9 The pleural fluid cultures were negative and other causes of fetal hydrops (Rh and ABO incompatibility, parvovirus infection, and chromosomal aneuploidies) were ruled out. Initially, the infant was clinically and biochemically euthyroid (Table 3) . However, on day 6 of life, the infant showed signs of thyrotoxicosis. Thyroid functions confirmed hyperthyroidism.
The infant was treated with propylthiouracil and propranolol. 
Clinical Perinatal Presentation
The infant was weaned off the medications over a period of 3 weeks without complications or signs of thyrotoxicosis. Over the first 5 days of life, the total pleural drainage was 500 ml. Chest tubes were removed on day 6 of life, and he was extubated on day 9 of life. Oral feeding was begun on day 7 of life (Portagen formula), selected because of its high medium-chain fatty acid content and reduced risk of reoccurrence of chylothorax. The infant's feeding was changed to a regular formula on day 14 of life. The patient has remained euthyroid and follow-up chest film revealed no re-accumulation of pleural fluid. He was discharged from the hospital in stable condition at 6 weeks of age.
Follow-up clinic visits demonstrated continuous suppression of thyroid-stimulating hormone for more than 12 months, but normal levels of T 4 RIA, FT 4 I, and THBR were noted. There has been no reoccurrence of chylothorax.
DISCUSSION
The association in this patient of fetal hydrops with congenital chylothorax requires elucidation. First, what is the association of fetal thyrotoxicosis with congenital chylothorax? The causative mechanism is probably heart failure secondary to tachyarrythmia. The exposure of fetal thyroid gland to thyroid-stimulating immunoglobulin in utero can cause hyperthyroidism. 10, 11 Fetal thyrotoxicosis is manifested by tachycardia and hyperkinesia and may be complicated by congestive heart failure. 12, 13 In heart failure, chylothorax may be produced by an increase in lymph production secondary to an augmented pulmonary capillary filtration associated with an obstruction to lymphatic flow caused by increased pressure in the left subclavian vein.
14, 15 Moreno et al. 16 reported an adult case of bilateral pleural effusions resulting from thyrotoxicosis without associated heart failure. Whatever the mechanism, the rare combination of fetal or neonatal thyrotoxicosis and chylothorax suggests that other unknown factors may play a role in the pathogenesis.
Second, the dramatic response of fetal hydrops to propylthiouracil and propranolol in the absence of other causes of immune and nonimmune hydrops points to fetal thyrotoxicosis as a direct cause of fetal hydrops and congenital chylothorax.
Third, this highlights the value of prenatal diagnosis followed by management in a tertiary care center as a means of reducing morbidity and the high mortality of congenital chylothorax and thyrotoxicosis.
To our knowledge, this is the first case reported of thyrotoxicosis presenting as pleural effusion (chylothorax) in the fetus or neonate. Chest tubes were immediately placed on either side, which produced a total of 300 ml of clear, serous fluid. Following this, the lungs were demonstrated to be normal. 
